Showing results (1-10 of 267) with videos related to
Sort By:
Pageof 27
British Journal of Clinical Pharmacology|February 24, 2011
Introduction to haemostasis from a pharmacodynamic perspectiveCornelis Kluft, Jacobus BurggraafContraception|March 27, 2012
Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EEMandana Rad, Jacobus Burggraaf, Marieke L de Kam, et al.British Journal of Clinical Pharmacology|December 21, 2002
Quantification of heparin-induced TFPI release: a maximum release at low heparin doseMichiel J B Kemme, Jacobus Burggraaf, Rik C Schoemaker, et al.International Journal of Clinical Pharmacology and Therapeutics|May 9, 2020
Interactions of sugammadex with various anticoagulants
Annelieke C Kruithof, Cornelis Kluft, Pieter-Jan de Kam, et al.International Journal of Clinical Pharmacology and Therapeutics|November 6, 2020
The mode of action of sugammadex on coagulationAnnelieke C Kruithof, Cornelis Kluft, Pieter-Jan de Kam, et al.Steroids|September 18, 2012
Increased impact of a contraceptive vaginal ring with ethinyl estradiol and nestorone on C-reactive proteinMandana Rad, Jacobus Burggraaf, Regine L Sitruk-Ware, et al.International Journal of Clinical Pharmacology and Therapeutics|January 23, 2014
Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjectsPieter-Jan De Kam, Peter Grobara, Marita Prohn, et al.Plos One|April 9, 2019
Whole blood assay as a model for in vitro evaluation of inflammasome activation and subsequent caspase-mediated interleukin-1 beta releaseThi Anh Thu Tran, Hendrika W Grievink, Katarzyna Lipinska, et al.American Journal of Obstetrics and Gynecology|March 21, 2006
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variablesMandana Rad, Cornelis Kluft, Joël Ménard, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 13, 2003
Endothelial binding of recombinant tissue plasminogen activator: quantification in vivo using a recirculatory modelMichiel J Kemme, Rik C Schoemaker, Jacobus Burggraaf, et al.Pageof 27